Table 1.

Clinical summary

Dose (μg)	Patient	Stage	Time to recurrence from surgery (months)	Survival from surgery (months)		Adjuvant therapya
				Alive	Died
100	1	T3 N1	11.0		28	Yes
	2	T3 N1	–	61	–	Yes
	3	T3 N1	11.0		12	Yes
	4	T3 N1	17.0		21	Yes
300	5b	T3 N1	3.0		4	No
	6	T3 N1	7.0		9	No
	7	T3 N0	9.0		10	Yes
	8	T3 N0	15.0		20	Yes
1,000	9	T3 N1	–	32	–	Yes
	10	T3 N1	7.0		8	No
	11	T2 N1	–		23	No
	12	T1 N1	7.0		8	No
3,000	13	T3 N1	6.0		10	No
	14	T3 N0	20.0		22	Yes
	15	T3 N1	10.0		13	No
	16	T4 N0	10.0		17	No

^aAdjuvant therapy consisting of external beam radiation therapy for 40–54 Gy with radiosensitizing doses of 5 FU was given in seven patients. Patient no. 2 received one cycle (3 weeks) of gemcitabine hydrochloride as adjuvant therapy

^bLocally advanced disease